Financial giants have made a conspicuous bullish move on Abbott Laboratories. Our analysis of options history for Abbott Laboratories ABT revealed 8 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $93,318, and 5 were calls, valued at $681,133.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $100.0 to $115.0 for Abbott Laboratories over the recent three months.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Abbott Laboratories options trades today is 2972.17 with a total volume of 4,909.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Abbott Laboratories's big money trades within a strike price range of $100.0 to $115.0 over the last 30 days.
Abbott Laboratories Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABT | CALL | SWEEP | NEUTRAL | 07/12/24 | $1.36 | $1.05 | $1.18 | $106.00 | $420.9K | 86 | 403 |
| ABT | CALL | TRADE | BULLISH | 08/16/24 | $1.12 | $1.06 | $1.11 | $110.00 | $166.5K | 5.7K | 109 |
| ABT | PUT | SWEEP | BEARISH | 07/12/24 | $0.7 | $0.63 | $0.7 | $102.00 | $35.0K | 25 | 20 |
| ABT | CALL | SWEEP | BULLISH | 11/15/24 | $1.96 | $1.85 | $1.96 | $115.00 | $34.4K | 1.4K | 4 |
| ABT | CALL | SWEEP | BULLISH | 07/12/24 | $1.04 | $1.03 | $1.04 | $106.00 | $32.8K | 86 | 4.2K |
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
After a thorough review of the options trading surrounding Abbott Laboratories, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Where Is Abbott Laboratories Standing Right Now?
- With a volume of 1,979,841, the price of ABT is down -0.59% at $104.26.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 21 days.
What The Experts Say On Abbott Laboratories
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $123.0.
- An analyst from Goldman Sachs has revised its rating downward to Buy, adjusting the price target to $121.
- In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $125.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Abbott Laboratories options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
